Imaging Diagnostics Systems' CT laser mammo gets closer to US
This article was originally published in Clinica
Imaging Diagnostics Systems' (IDS) CT laser mammography (CTLM) system is edging closer to the US market, the company told Clinica, after enrolling a tenth site in clinical trials of the technology. Results of the study will be used in its premarket approval (PMA) application to the US FDA. The Fort Lauderdale, Florida company may add two further sites to the trial to "further shorten the time" needed to collect enough patient data to submit for approval.
You may also be interested in...
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.